BACKGROUND: Prevalence of multidrug-resistant microorganisms (MDROs) continues to increase, while infection control gaps in healthcare settings facilitate their transmission between patients. In this setting, 5 distinct yet interlinked pathways are responsible for transmission. The complete transmission process is still not well understood. Designing and conducting a single research study capable of investigating all 5 complex and multifaceted pathways of hospital transmission would be costly and logistically burdensome. Therefore, this scoping review aims to synthesize the highest-quality published literature describing each of the 5 individual potential transmission pathways of MDROs in the healthcare setting and their overall contribution to patient-to-patient transmission. METHODS: In 3 databases, we performed 2 separate systematic searches for original research published during the last decade. The first search focused on MDRO transmission via the HCW or the environment to identify publications studying 5 specific transmission pathways: (1) patient to HCW, (2) patient to environment, (3) HCW to patient, (4) environment to patient, and (5) environment to HCW. The second search focused on overall patient-to-patient transmission regardless of the transmission pathway. Both searches were limited to transmission of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus, multidrug-resistant A. baumannii, and carbapenem-resistant Enterobacteriaceae. After abstract screening of 5,026 manuscripts, researchers independently reviewed and rated the remaining papers using objective predefined criteria to identify the highest quality and most influential manuscripts. RESULTS: High-quality manuscripts were identified for all 5 routes of transmission. Findings from these studies were consistent for all pathways; however, results describing the routes from the environment/HCW to a noncolonized patient were more limited and variable. Additionally, most research focused on MRSA, instead of other MDROs. The second search yielded 10 manuscripts (8 cohort studies) that demonstrated the overall contribution of patient-to-patient transmission in hospitals regardless of the transmission route. For MRSA, the reported cross-transmission was as high as 40%. CONCLUSIONS: This scoping review brings together evidence supporting all 5 possible transmission pathways and illustrates the complex nature of patient-to-patient transmission of MDROs in hospitals. Our findings also confirm that transmission of MDROs in hospitals occurs frequently, suggesting that ongoing efforts are necessary to strengthen infection prevention and control to prevent the spread of MDROs.
BACKGROUND: Prevalence of multidrug-resistant microorganisms (MDROs) continues to increase, while infection control gaps in healthcare settings facilitate their transmission between patients. In this setting, 5 distinct yet interlinked pathways are responsible for transmission. The complete transmission process is still not well understood. Designing and conducting a single research study capable of investigating all 5 complex and multifaceted pathways of hospital transmission would be costly and logistically burdensome. Therefore, this scoping review aims to synthesize the highest-quality published literature describing each of the 5 individual potential transmission pathways of MDROs in the healthcare setting and their overall contribution to patient-to-patient transmission. METHODS: In 3 databases, we performed 2 separate systematic searches for original research published during the last decade. The first search focused on MDRO transmission via the HCW or the environment to identify publications studying 5 specific transmission pathways: (1) patient to HCW, (2) patient to environment, (3) HCW to patient, (4) environment to patient, and (5) environment to HCW. The second search focused on overall patient-to-patient transmission regardless of the transmission pathway. Both searches were limited to transmission of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus, multidrug-resistant A. baumannii, and carbapenem-resistant Enterobacteriaceae. After abstract screening of 5,026 manuscripts, researchers independently reviewed and rated the remaining papers using objective predefined criteria to identify the highest quality and most influential manuscripts. RESULTS: High-quality manuscripts were identified for all 5 routes of transmission. Findings from these studies were consistent for all pathways; however, results describing the routes from the environment/HCW to a noncolonized patient were more limited and variable. Additionally, most research focused on MRSA, instead of other MDROs. The second search yielded 10 manuscripts (8 cohort studies) that demonstrated the overall contribution of patient-to-patient transmission in hospitals regardless of the transmission route. For MRSA, the reported cross-transmission was as high as 40%. CONCLUSIONS: This scoping review brings together evidence supporting all 5 possible transmission pathways and illustrates the complex nature of patient-to-patient transmission of MDROs in hospitals. Our findings also confirm that transmission of MDROs in hospitals occurs frequently, suggesting that ongoing efforts are necessary to strengthen infection prevention and control to prevent the spread of MDROs.
Authors: Heather L Colquhoun; Danielle Levac; Kelly K O'Brien; Sharon Straus; Andrea C Tricco; Laure Perrier; Monika Kastner; David Moher Journal: J Clin Epidemiol Date: 2014-07-14 Impact factor: 6.437
Authors: Sean L Barnes; Daniel J Morgan; Anthony D Harris; Phillip C Carling; Kerri A Thom Journal: Infect Control Hosp Epidemiol Date: 2014-07-25 Impact factor: 3.254
Authors: Anthony D Harris; Lisa Pineles; Beverly Belton; J Kristie Johnson; Michelle Shardell; Mark Loeb; Robin Newhouse; Louise Dembry; Barbara Braun; Eli N Perencevich; Kendall K Hall; Daniel J Morgan; Syed K Shahryar; Connie S Price; Joseph J Gadbaw; Marci Drees; Daniel H Kett; L Silvia Muñoz-Price; Jesse T Jacob; Loreen A Herwaldt; Carol A Sulis; Deborah S Yokoe; Lisa Maragakis; Matthew E Lissauer; Marcus J Zervos; David K Warren; Robin L Carver; Deverick J Anderson; David P Calfee; Jason E Bowling; Nasia Safdar Journal: JAMA Date: 2013-10-16 Impact factor: 56.272
Authors: Randy W Loftus; Matthew D Koff; Jeremiah R Brown; Hetal M Patel; Jens T Jensen; Sundara Reddy; Kathryn L Ruoff; Stephen O Heard; Mark P Yeager; Thomas M Dodds Journal: Anesth Analg Date: 2015-04 Impact factor: 5.108
Authors: Mary K Hayden; Donald W Blom; Elizabeth A Lyle; Charity G Moore; Robert A Weinstein Journal: Infect Control Hosp Epidemiol Date: 2008-02 Impact factor: 3.254
Authors: J Kristie Johnson; Gwen Smith; Mary S Lee; Richard A Venezia; O Colin Stine; James P Nataro; William Hsiao; Anthony D Harris Journal: J Infect Dis Date: 2009-09-15 Impact factor: 5.226
Authors: Mai T Pham; Andrijana Rajić; Judy D Greig; Jan M Sargeant; Andrew Papadopoulos; Scott A McEwen Journal: Res Synth Methods Date: 2014-07-24 Impact factor: 5.273
Authors: Aline Wolfensberger; Nora Mang; Kristen E Gibson; Lona Mody; Hugo Sax; Kyle Gontjes; Marco Cassone; Silvio D Brugger Journal: Infect Control Hosp Epidemiol Date: 2021-08-27 Impact factor: 6.520
Authors: Jin Ju Park; Yu Bin Seo; Jacob Lee; Joong Sik Eom; Wonkeun Song; Young Kyun Choi; Sung Ran Kim; Hee Jung Son; Nan Hyoung Cho Journal: J Korean Med Sci Date: 2020-09-14 Impact factor: 2.153
Authors: J M van Niekerk; M Lokate; L M A Braakman-Jansen; J E W C van Gemert-Pijnen; A Stein Journal: BMC Infect Dis Date: 2022-01-20 Impact factor: 3.090
Authors: Valentina Dazio; Aurélien Nigg; Janne S Schmidt; Michael Brilhante; Edgar I Campos-Madueno; Nico Mauri; Stefan P Kuster; Stefanie Gobeli Brawand; Barbara Willi; Andrea Endimiani; Vincent Perreten; Simone Schuller Journal: One Health Date: 2021-08-31
Authors: Priscila Pinho da Silva; Fabiola A da Silva; Caio Augusto Santos Rodrigues; Leonardo Passos Souza; Elisangela Martins de Lima; Maria Helena B Pereira; Claudio Neder Candella; Marcio Zenaide de Oliveira Alves; Newton D Lourenço; Wagner S Tassinari; Christovam Barcellos; Marisa Zenaide Ribeiro Gomes Journal: Antimicrob Resist Infect Control Date: 2021-06-16 Impact factor: 4.887